M. Ooka et al., Bone marrow micrometastases detected by RT-PCR for mammaglobin can be an alternative prognostic factor of breast cancer, BREAST CANC, 67(2), 2001, pp. 169-175
Purpose. To evaluate a new prognostic factor of breast cancer, bone marrow
micrometastases which was detected by RT-PCR for mammaglobin, a sensitive m
olecular marker of breast cancer, was examined.
Materials and methods. One hundred and eleven samples from stage I-III brea
st cancer patients were examined. Bone marrow micrometastases and clinicopa
thological parameters, which were age, tumor size, lymph node metastasis an
d status of the estrogen receptor, were evaluated for the prognostic factor
by statistical analysis.
Results. Median follow-up time was 21.1 months. Thirty-three (29.7 %) out o
f 111 samples were RT-PCR positive. Eight cases (24.2 %) in this group show
ed recurrent lesions in the distant organs. Whereas six (7.7 %) out of 78 R
T-PCR negative patients had distant recurrences. In the premenoposal patien
ts, and in the patients with axillary lymph node metastases, RT-PCR positiv
e cases showed significantly higher distant recurrent rate. Bone marrow mic
rometastases, axillary nodal status, and estrogen receptor were independent
prognostic factors for breast cancer by both univariate and multivariate a
nalysis.
Conclusions. Bone marrow micrometastases detected by RT-PCR for mammaglobin
can be a useful predictive marker for early distant recurrence of breast c
ancer.